Is APOA2 useful for Wechseljahre?

The utility of APOA2 for menopause is not supported by direct evidence. APOA2 encodes apolipoprotein A-II, a component of HDL, and is linked to lipid metabolism, appetite regulation, and BMI. The rs5082 variant (C allele) has been associated with higher food intake under high-fat diets. Menopause involves estrogen decline, often leading to weight gain and dyslipidemia. In theory, APOA2 genotyping could help personalize dietary fat recommendations. However, no studies specifically examine APOA2 in the context of menopausal symptoms, hormone changes, or long-term outcomes. The evidence is 'mixed': mechanistic and population-level associations exist, but clinical utility for menopause is unproven. Thus, APOA2 testing may be considered a minor adjunct within a broader metabolic assessment, not a standalone tool. Established approaches—hormonal evaluation, lipid panels, lifestyle interventions—remain paramount. Consumers should be cautious of overinterpretation. A DNA test does not replace medical advice.